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The association between low HDL cho-
lesterol (HDL-C) concentrations and in-
creased cardiovascular risk is well
established. Low HDL-C levels were
found in subjects with type 1 diabetes
(T1D) who presented complications (1)
and in untreated subjects with celiac
disease (CD). The association between
TID and CD might therefore enhance
this lipid abnormality and accelerate
the atherosclerotic process.
We collected data from 13 centers
belonging to the Italian Society of Pedi-
atric Endocrinology and Diabetology
(ISPED) of a large number of children
with both T1D and concurrent biopsy-
proven CD, at the exact time point a
gluten-free diet (GFD) was initiated and
after 1 year of a GFD, verified by means
of CD-related antibodies. A total of 201
children with T1D diagnosed at age of
5.8 6 3.8 years and CD diagnosed at age
of 7.56 4.5 years were enrolled. We in-
cluded only the cases in which CD diag-
nosis was made at least 3 months after
that of T1D to avoid a potential influence
of the metabolic derangement at diabe-
tes onset. As a control group, we used a
group of 224 patients with T1D only,
matched by age, sex, diabetes duration,
and HbA1c.
Before GFD was initiated, HDL-C val-
ues were significantly lower in children
with CD and T1D than in the control
group, and the greatest decrease was
found in younger children aged ,6
years (Table 1). The subjects with HDL-C
values lower than pediatric percentile
cut points for sex and age were younger
than those with normal values (6.2 6
4.4 vs. 8.6 6 4.3 years, P , 0.0001) and
had lower HbA1c (7.5 6 0.8 vs. 8.0 6
1.5%, P , 0.005).
After GFD, the mean values of HDL-C
in the total study population signifi-
cantly increased (60.96 13.7 vs. 51.3 6
13.6 mg/dL, P , 0.0001) and normal-
ized. In children ,6 years of age, the
increase in HDL-C values was greater
than in older children (28 vs. 13%) The
percentage of subjects with HDL-C val-
ues lower than pediatric percentile cut
points fell significantly (P , 0.0001)
from 42 to 16%. Subjects with complete
adherence to GFD showed the most sig-
nificant improvement of HDL-C, and sub-
jects with partial adherence showed a
lower, but significant, improvement of
HDL-C.
Our results confirmother data reported
in the past few years (2–4) but showed a
more evident reduction in HDL-C at diag-
nosis and a greater restore after GFD. This
reduction of HDL-C has been interpreted
as a proxy marker for intestinal inflamma-
tion or as a consequence of altered intes-
tinal secretion of apolipoprotein AI (5), the
major HDL structural protein. This occurs
most considerably in the youngest chil-
dren who probably have a more severe
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disease, as suggested by the presence of
signs of malabsorption, e.g., lower HDL-C
and HbA1c levels.
An unfavorable lipid profile, i.e., low
HDL-C values, characterizes children
with T1D and untreated CD, especially
the youngest. GFD is able to normalize
HDL-C levels and the more marked ben-
eficial effect of glutenwithdrawal can be
found in individuals who adhere to the
GFD and in the youngest individuals.
Therefore, a strict GFD is mandatory in
these children, as they may be at in-
creased risk of cardiovascular disease.
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Table 1—HDL-C levels (mg/dL) in children with T1D alone and with T1D and CD before and after starting a GFD
Patients with T1D and CD (n 5 201)
Patients with T1D only (n 5 224)Before GFD P After GFD
All cases (n 5 201) 51.3 6 13.6* ,0.0001 60.9 6 13.7 65.1 6 30.8
Age ,6 years (n 5 90) 46.5 6 13.6*† ,0.0001 59.2 6 12.8
Age .6 years (n 5 111) 55.2 6 12.3‡ ,0.0001 62.4 6 14.3
Adherence to GFD diet
Poor (n 5 33) 51.8 6 14.1§ NS 56.6 6 13.5
Partial (n 5 39) 54.9 6 12.0§ ,0.05 64.2 6 14.1
Complete (n 5 129) 50.1 6 13.8* ,0.0001 61.1 6 13.4
Data are mean 6 SD, unless stated otherwise. NS, not significant. *P , 0.0001, ‡P , 0.001, §P , 0.05 vs. control subjects. †P , 0.0001 vs. aged
.6 years.
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